AI scoring tool may guide skin biopsy decision
Mayo Clinic researchers have found that an artificial intelligence (AI) tool may provide dermatologists with additional information to help assess whether skin lesions are cancerous and inform their clinical decisions about whether to biopsy or monitor them, according to a study published in Mayo Clinic Proceedings.
Read original article on The Medical News →Related news
-
Blood test can help clinicians better identify brain injury severity in patients
United Kingdom
-
Study links recreational cannabis legalization to rising heart attack admissions
United Kingdom
-
Standardized protocol enables safer kidney biopsies in high-risk patients
United Kingdom
-
Social determinants of health may increase kidney failure risk after critical illness
United Kingdom
-
Potassium binder helps dialysis patients manage dietary restrictions
United Kingdom
-
Fruits and vegetables may be a better option to improve kidney disease outcomes
United Kingdom
-
New clinical decision support tool aims to improve chronic kidney disease care
United Kingdom
-
$8.2 million grant advances on-demand male contraceptive development
United Kingdom